RxDoctor Payments Data

Soheila Yadrandji, MD

Anatomic Pathology & Clinical Pathology · Lansdowne, VANPI 1033104054

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 31.1% of the total. Reporting peaked in 2021 at $151 and has fallen 58.4% since, to $63 in 2025.

$604in general payments, 2019–2025

Across 31 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$188
  • Regeneron Healthcare Solutions, Inc.$159
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$71
  • Takeda Pharmaceuticals U.S.A., Inc.$59
  • QOL Medical, LLC$34
  • Intercept Pharmaceuticals, Inc.$25
  • plus $68 from 4 others

What the payments were for

  • Food & beverage$604100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$604 in reported general payments places this provider in the 85th percentile of 156 anatomic pathology & clinical pathology providers in Virginia.

See all anatomic pathology & clinical pathology providers in Virginia

Medicare billing

Part B allowed, 2024
$168,134
Medicare patients
533
Services billed
2,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Lansdowne

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →